![]() in Economics & Business from UCLA, and then went across town to USC to earn his M.B.A., where he received a concentration in Entrepreneurship and was the Price Institute of Entrepreneurship Fellow.ĭorothy is based in our Santa Monica office. All told, Jay has worked with more than 30 early stage companies, including “traditional” start-ups as well as “intrapreneurially” building businesses for mature corporations such as Disney, Reed Elsevier (London) and Summa Group (Moscow). He is a 4X CEO, 2X President, 5X COO, 1X CFO, 2X EVP/SVP, and 1X Board Chairman of early stage companies, and has served in an advisory role for numerous other start-ups. Prior to his role with Wavemaker 360, Jay spent his entire professional career working with and for early stage companies. Moreover, countless business models are now, for the first time, commercially viable because the healthcare industry is embracing value-based payments. GDP! There will be no shortage of clinical operations and business challenges to solve in the coming decade, and entrepreneurs are already coming out of the woodwork to solve these problems. Remember, healthcare is a $3 trillion industry representing almost 20% of the U.S. The fund’s investment thesis is that after 40 years, healthcare is transitioning away from fee-for-service to value-based payments, and with that comes a massive amount of disruption. Jay Goss is a General Partner with Wavemaker Three-Sixty Health, a new LA-based venture fund focused on healthcare start-ups seeking Seed and Series A investment. Kwame has served in progressive leadership roles at the US Food and Drug Administration (FDA) and personally evaluated over 1,000 medical technologies. He led efforts to shorten global registration timelines, improved product quality by process optimization and achieve best-in-class department engagement scores. Ulmer previously served as Vice President, Regulatory Affairs and Quality Assurance at Implant Direct, a Danaher Corporation operating company. He is currently an Angel Investor and regulatory strategy consultant with a focus on MedTech and Venture Capital firms. Kwame Ulmer is a MedTech executive with nearly twenty years of experience in government and the private sector. Join Biocom and a panel of experts from Royse Law Firm, MedTech Innovator, Ulmer Ventures, and Wavemaker 360 Health as we discuss ways to structure, scale, and increase the likelihood of your company succeeding after seed funding.ĥ:15pm – 5:30pm | Welcoming Remarks (Brian Benson, Magnify at CNSI)
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |